Cite
HARVARD Citation
Bartoletti, M. et al. (2020). Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva. International journal of gynecological cancer. 30 (11), pp. 1672-1677. [Online].